Rehasport Clinic Report issue

Academic/Hospital Phase 2
Founded: Poznań Poland (2011)

Organization Overview

First Clinical Trial
2018
NCT04321629
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Rehasport Clinic

Active Ingredients

Drugs in Phase 2 Trials (1)

platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Joint Diseases (Phase 2)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1